How much does the cheapest version of Crizotinib cost?
Crizotinib is a targeted drug used to treat ALK positive non-small cell lung cancer (NSCLC). It has been officially launched in China and has been included in the medical insurance catalog. Its original drug was developed by Pfizer and has brought significant treatment improvements to lung cancer patients after entering the market. Although this drug is available in China, the price of the original drug is still high, especially for patients who do not enjoy medical insurance reimbursement, and the financial burden is still large.
Crizotinib is currently sold in two specifications in China, namely 250mg 60 tablets and 200mg 60 tablets. Each box usually sells for more than 10,000 yuan. Although it has been included in medical insurance, the proportion and amount of medical insurance reimbursement are closely related to the medical insurance policy of the patient's location. Patients in some areas still need to bear a considerable part of the drug expenses out of their own pocket. For patients with limited financial resources, this price cannot be ignored, so finding more affordable alternatives has become a real need.

In overseas markets, the price of the original drug crizotinib is also high. Taking the European and American versions as an example, the price of the 250mg original drug is often around RMB 10,000, or even higher. The price fluctuates due to multiple factors such as exchange rates and regional policies. However, it is worth noting that many countries and regions have launched generic drugs of crizotinib. These drugs have basically the same ingredients and specifications as the original drugs, and their efficacy has also passed clinical verification, but their prices are more advantageous.
Take the generic version of crizotinib produced by Lucius Pharmaceutical Factory in Laos as an example. 250mg*60 Each box of 250mg*60 tablets sells for about more than 1,000 yuan, which is much more cost-effective than the original drug. This generic drug has been legally marketed locally and has formal production qualifications. It is an important choice for many patients to reduce treatment costs. For patients who want long-term medication, this lower-priced generic version provides great economic relief while also ensuring the continuity and standardization of treatment. If you consider purchasing drugs overseas, it is recommended to obtain them through formal channels to ensure drug quality and medication safety.
Reference materials:https://go.drugbank.com/drugs/DB08865
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)